What Should You Know about COVID-19 Vaccines and Pregnancy
What should I know about COVID-19 vaccines if I’m pregnant? Vaccination is likely the best way to prevent COVID-19 in pregnancy, when risks for severe illness and death from the virus are higher than usual. The American College of Obstetricians and Gynecologists says COVID-19 vaccinations should not be withheld from pregnant women, and that women should discuss individual risks and benefits with their health care providers. The U.S. government’s emergency authorization for the Pfizer and Moderna vaccines being rolled out for priority groups doesn’t list pregnancy as a reason to withhold the ...
Source: JEMS Patient Care - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Medicine Source Type: news

What Should You Know about COVID-19 Vaccines and Pregnancy
What should I know about COVID-19 vaccines if I’m pregnant? Vaccination is likely the best way to prevent COVID-19 in pregnancy, when risks for severe illness and death from the virus are higher than usual. The American College of Obstetricians and Gynecologists says COVID-19 vaccinations should not be withheld from pregnant women, and that women should discuss individual risks and benefits with their health care providers. The U.S. government’s emergency authorization for the Pfizer and Moderna vaccines being rolled out for priority groups doesn’t list pregnancy as a reason to withhold the ...
Source: JEMS Administration and Leadership - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Medicine Source Type: news

What Should You Know about COVID-19 Vaccines and Pregnancy
What should I know about COVID-19 vaccines if I’m pregnant? Vaccination is likely the best way to prevent COVID-19 in pregnancy, when risks for severe illness and death from the virus are higher than usual. The American College of Obstetricians and Gynecologists says COVID-19 vaccinations should not be withheld from pregnant women, and that women should discuss individual risks and benefits with their health care providers. The U.S. government’s emergency authorization for the Pfizer and Moderna vaccines being rolled out for priority groups doesn’t list pregnancy as a reason to withhold the ...
Source: JEMS Latest News - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Medicine Source Type: news

What Should You Know about COVID-19 Vaccines and Pregnancy
What should I know about COVID-19 vaccines if I’m pregnant? Vaccination is likely the best way to prevent COVID-19 in pregnancy, when risks for severe illness and death from the virus are higher than usual. The American College of Obstetricians and Gynecologists says COVID-19 vaccinations should not be withheld from pregnant women, and that women should discuss individual risks and benefits with their health care providers. The U.S. government’s emergency authorization for the Pfizer and Moderna vaccines being rolled out for priority groups doesn’t list pregnancy as a reason to withhold the ...
Source: JEMS Operations - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Medicine Source Type: news

What Should You Know about COVID-19 Vaccines and Pregnancy
What should I know about COVID-19 vaccines if I’m pregnant? Vaccination is likely the best way to prevent COVID-19 in pregnancy, when risks for severe illness and death from the virus are higher than usual. The American College of Obstetricians and Gynecologists says COVID-19 vaccinations should not be withheld from pregnant women, and that women should discuss individual risks and benefits with their health care providers. The U.S. government’s emergency authorization for the Pfizer and Moderna vaccines being rolled out for priority groups doesn’t list pregnancy as a reason to withhold the ...
Source: JEMS: Journal of Emergency Medical Services News - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Medicine Source Type: news

What Should You Know about COVID-19 Vaccines and Pregnancy
What should I know about COVID-19 vaccines if I’m pregnant? Vaccination is likely the best way to prevent COVID-19 in pregnancy, when risks for severe illness and death from the virus are higher than usual. The American College of Obstetricians and Gynecologists says COVID-19 vaccinations should not be withheld from pregnant women, and that women should discuss individual risks and benefits with their health care providers. The U.S. government’s emergency authorization for the Pfizer and Moderna vaccines being rolled out for priority groups doesn’t list pregnancy as a reason to withhold the ...
Source: JEMS Special Topics - January 14, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Medicine Source Type: news

Model analyzes how viruses escape the immune system
(Massachusetts Institute of Technology) MIT researchers have devised a way to computationally model viral escape, using models that were originally developed to model language. The model can predict which sections of viral surface proteins, including those of influenza, HIV, and SARS-CoV-2, are more likely to mutate in a way that allows the virus to evade the human immune system. It can also identify sections that are less likely to mutate, making them good targets for new vaccines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 14, 2021 Category: Infectious Diseases Source Type: news

Learning the language of viral evolution and escape
The ability for viruses to mutate and evade the human immune system and cause infection, called viral escape, remains an obstacle to antiviral and vaccine development. Understanding the complex rules that govern escape could inform therapeutic design. We modeled viral escape with machine learning algorithms originally developed for human natural language. We identified escape mutations as those that preserve viral infectivity but cause a virus to look different to the immune system, akin to word changes that preserve a sentence’s grammaticality but change its meaning. With this approach, language models of influenza ...
Source: ScienceNOW - January 14, 2021 Category: Science Authors: Hie, B., Zhong, E. D., Berger, B., Bryson, B. Tags: Computers, Mathematics, Immunology reports Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Health - January 11, 2021 Category: Consumer Health News Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Science - January 11, 2021 Category: Science Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

$2.25 million NIH grant enables exploration of a pathway to better vaccines
(Medical College of Georgia at Augusta University) To build better vaccines, scientists want to know more about how our bodies make adequate numbers of effective, durable antibodies against the influenza virus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 11, 2021 Category: International Medicine & Public Health Source Type: news

GPs in England see big drop in common cold and flu cases
Exclusive: coronavirus restrictions and increased uptake of flu vaccine is likely explanation, say expertsCoronavirus – latest updatesSee all our coronavirus coverageGPs in England have reported a big drop in cases of influenza, colds and other common infections – with cold rates now about a quarter of the five-year average, and flu at about a 20th of the usual level for this time of year.Social restrictions brought in to curb transmission of coronavirus combined with an increased uptake of flu vaccine is the most likely explanation, experts say.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 10, 2021 Category: Science Authors: Linda Geddes Tags: Coronavirus Flu Common cold World news Infectious diseases Medical research Society Science Health policy England UK news GPs Source Type: news

Laws Promoting Flu Shot for Hospital Workers Can Cut Deaths
FRIDAY, Jan. 8, 2021 -- State laws promoting hospital worker vaccination against influenza may be effective for reducing monthly pneumonia and influenza mortality rates, especially among the elderly, according to a study published online Jan. 5 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 8, 2021 Category: Pharmaceuticals Source Type: news

The COVID-19 Virus Is Mutating. What Does That Mean for Vaccines?
As we enter the second year of living with the new coronavirus SARS-CoV-2, the virus is celebrating its invasion of the world’s population with yet more mutated forms that help it to spread more easily from person to person. One, first detected in the U.K. in December, has already raised alarms about whether the COVID-19 virus is now escaping from the protection that vaccines just being rolled out now might provide. The variant has also been found in the U.S. Already, U.K. officials have tightened lockdowns in England, Scotland and Wales, and over the holidays, more than 40 countries banned travelers from the region ...
Source: TIME: Health - January 7, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

If Covid-19 is Primarily a ‘First World’ Virus, Why is the Global South in Lockdown?
A lockdown closer home. Secretary-General Antonio Guterres walking the empty corridors of the UN Secretariat building in New York in 2020. Credit: United NationsBy Darini Rajasingham-SenanayakeCOLOMBO, Sri Lanka, Jan 7 2021 (IPS) The currently available Covid-19 vaccines have been authorized for ‘emergency use ‘in Europe and North America. This is due to an apparent spike in Covid-19 flu cases in the northern hemisphere as winter advances. Highly advertised vaccines are being produced and rolled out at ‘warped speed’ by powerful pharmaceutical and bio-technology companies headquartered in Euro-Ameri...
Source: IPS Inter Press Service - Health - January 7, 2021 Category: International Medicine & Public Health Authors: Darini Rajasingham-Senanayake Tags: Aid Development & Aid Editors' Choice Featured Global Headlines Health Human Rights IPS UN: Inside the Glasshouse Population Poverty & SDGs TerraViva United Nations Source Type: news

Flu Activity Currently Lower Than Last 2 Seasons In Massachusetts
BOSTON (CBS) – Flu activity is currently low in Massachusetts, a good sign as the state struggles like the rest of the country with the coronavirus pandemic. According to the latest weekly flu report from the Department of Public Health, the percent of “influenza-like illness visits” to hospitals and outpatient facilities is at 1.11 percent. That’s lower than the previous two seasons in the same week. The percentage of hospitalizations is also lower than the last two flu seasons at this time. The report said “all regions are reporting minimal influenza-like illness activity.” Authorities...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 6, 2021 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Healthwatch Syndicated CBSN Boston Syndicated Local Coronavirus Flu influenza Source Type: news

Influenza vaccination cost effective in primary school children
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - January 1, 2021 Category: Drugs & Pharmacology Source Type: news

Don ’t Let the Pandemic Stop Your Shots
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That ’s not wise, health experts say. (Source: NYT Health)
Source: NYT Health - December 28, 2020 Category: Consumer Health News Authors: Paula Span Tags: your-feed-science Whooping Cough Shingles (Disease) Diphtheria Coronavirus (2019-nCoV) Influenza Elderly Epidemics Drugs (Pharmaceuticals) Pneumonia your-feed-healthcare Vaccination and Immunization Hepatitis Tetanus Minorities Source Type: news

Covid Vaccine During Pregnancy? Even Doctors Struggle With This Question
A doctor struggles with the lack of data surrounding the Covid-19 vaccine and pregnancy. (Source: NYT Health)
Source: NYT Health - December 22, 2020 Category: Consumer Health News Authors: Mara Gordon, M.D. Tags: Pregnancy and Childbirth Clinical Trials Vaccination and Immunization Workplace Hazards and Violations Protective Clothing and Gear Influenza Source Type: news

What You Can Do Post-Vaccine, and When
Particularly in the early months of vaccination, many activities should wait, experts say — and plan to keep your masks. (Source: NYT Health)
Source: NYT Health - December 21, 2020 Category: Consumer Health News Authors: Claire Cain Miller, Margot Sanger-Katz and Katherine J. Wu Tags: Vaccination and Immunization Content Type: Service Coronavirus (2019-nCoV) Influenza Disease Rates Source Type: news

Uganda: Is Uganda Ready to Acquire the Covid-19 Vaccine?
[Monitor] The world's population, years over, has been affected by a number of viral diseases such a Ebola and Influenza which, in some cases, have caused millions of deaths. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 21, 2020 Category: African Health Source Type: news

The Coronavirus Is Mutating. What Does That Mean for Us?
Officials in Britain and South Africa claim new variants are more easily transmitted. There ’s a lot more to the story, scientists say. (Source: NYT Health)
Source: NYT Health - December 20, 2020 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Vaccination and Immunization Immune System Antibodies Influenza Evolution (Biology) Genetics and Heredity Viruses Source Type: news

CDC: Fewer-than-normal flu cases may be due to increased vaccination
Well under 1% of nasal and throat samples screened for influenza nationally have tested positive for the seasonal virus, according to figures released Friday by the U.S. Centers for Disease Control and Prevention. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 18, 2020 Category: Consumer Health News Source Type: news

What Makes COVID-19 Different From the Flu?
Living through the COVID-19 pandemic is hard. TIME’s advice column is here to help. Trying to decide if that dinner party is safe to attend? Fighting through your quarantine fatigue? Our health reporters will consult experts who can help find a safe and practical solution. Send us your pandemic dilemmas at covidquestions@time.com, and we will choose some to answer in a column on TIME.com. Today, Judy Jones from Missouri asks: Please help. I have a few friends who refuse to take the risks of COVID-19 seriously. They claim that it is no worse than the flu, and that there have always been a certain amount of deaths each...
Source: TIME: Health - December 17, 2020 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID Questions COVID-19 Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Special Topics - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Operations - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS: Journal of Emergency Medical Services News - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Latest News - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Administration and Leadership - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

Emergency Considerations in COVID-19 Vaccine Administration
Conclusion The joint response of science and medicine to develop safe and effective COVID-19 vaccines has been brisk and productive. Distribution efforts will now be the next step in limiting the breadth of this pandemic. EMS agencies will play a key role in some areas in the administration of vaccinations for their communities. The authors suggest that to better clarify the side effects of the COVID-19 vaccines, EMS systems must maintain a log of the type and incidence of adverse events following vaccine administration, EMS responses to the adverse events, as well as those patients’ outcomes from this manageme...
Source: JEMS Patient Care - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus Exclusives EMS EMT Paramedic Source Type: news

High-Dose Trivalent Flu Shot No Better for Patients With CVD
TUESDAY, Dec. 15, 2020 -- For patients with high-risk cardiovascular disease, high-dose trivalent inactivated influenza vaccination does not reduce cardiopulmonary hospitalization or all-cause mortality compared with standard-dose quadrivalent... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 15, 2020 Category: Pharmaceuticals Source Type: news

Consumer Health: It's flu season -- have you been vaccinated?
Influenza is a viral infection that attacks your respiratory system, including your nose, throat and lungs. Influenza is commonly called the flu, but it's not the same as stomach flu, which is an intestinal infection marked by watery diarrhea, abdominal cramps, nausea or vomiting, and sometimes fever. For most people, the flu resolves on its own. But [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 15, 2020 Category: Databases & Libraries Source Type: news

Fears of a ‘Twindemic’ Recede as Flu Lies Low
Despite early worries, flu patients are not competing with Covid-19 patients for ventilators, and the threat of dueling outbreaks may be waning. (Source: NYT Health)
Source: NYT Health - December 13, 2020 Category: Consumer Health News Authors: Donald G. McNeil Jr. Tags: Coronavirus (2019-nCoV) Influenza Vaccination and Immunization Medicine and Health Centers for Disease Control and Prevention your-feed-health your-feed-science Winter (Season) Preventive Medicine Kinsa Inc Source Type: news

Pre-existing flu immunity impacts antibody quality following infection and vaccination
(University of Chicago Medical Center) New research by scientists at the University of Chicago suggests a person's antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals who are vaccinated or naturally infected. Their results highlight the importance of receiving the annual flu vaccine to induce the most protective immune response. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2020 Category: International Medicine & Public Health Source Type: news

Pfizer/BioNTech ’s COVID-19 Vaccine Gets a Major Endorsement from FDA Committee
In a 17-4 vote (with one abstention) the U.S. Food and Drug Administration’s (FDA) vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the American public. With that recommendation hand, an FDA team led by the agency’s commissioner Dr. Stephen Hahn will now make a final decision about whether to issue an emergency use authorization (EUA) for the vaccine for anyone 16 years and older. The committee vote is not binding, but the agency is likely follow its advice, especially given the urgent need for a vaccine to stave off a rising tide of new infections. T...
Source: TIME: Health - December 11, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

The First Authorized COVID-19 Vaccine in the U.S. Has Arrived
Late in the evening on Dec. 11, the U.S. Food and Drug Administration (FDA) authorized the first COVID-19 vaccine for use in the country. The emergency use authorization means that doses of the vaccine—made by Pfizer/BioNTech—can be shipped at any time; certain Americans could be vaccinated as soon as next week. In a statement, FDA commissioner Dr. Stephen Hahn said “The FDA’s authorization for emergency use of the first COVID-19 vaccine is a significant milestone in battling this devastating pandemic that has affected so many families in the United States and around the world.” In the same pr...
Source: TIME: Health - December 11, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

MEDICAL EUGENICS: Flu shots are mandatory at Cornell for White people, but "People of Color" (POC) are granted exemptions
(Natural News) All students enrolled at Cornell University are required to be vaccinated for influenza, unless they qualify as black, “indigenous,” or a “person of color,” in which case they can apply for an exemption. Because flu shots make some “BIPOC” people, as they call them, uncomfortable, Cornell has decided to allow them medical exemptions... (Source: NaturalNews.com)
Source: NaturalNews.com - December 9, 2020 Category: Consumer Health News Source Type: news

Here ’s Why Vaccinated People Still Need to Wear a Mask
The new vaccines will probably prevent you from getting sick with Covid. No one knows yet whether they will keep you from spreading the virus to others — but that information is coming. (Source: NYT Health)
Source: NYT Health - December 8, 2020 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Clinical Trials Tests (Medical) Preventive Medicine Nose Antibodies Disease Rates Immune System Coronavirus (2019-nCoV) Throat Influenza AstraZeneca PLC Johnson & Moderna Inc Pfizer Inc Source Type: news

Afluria Quadrivalent 2020 (2020 Influenza Vaccine Suspension for Intramuscular Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 7, 2020 Category: Drugs & Pharmacology Source Type: news

Mount Sinai researchers advance a universal influenza virus vaccine
(The Mount Sinai Hospital / Mount Sinai School of Medicine) A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 7, 2020 Category: International Medicine & Public Health Source Type: news

What Areas of the Physical Examination are Important in the Pre-participation Physical Examination?
Discussion Participation in organized or non-organized, recreational to elite sports activities can provide excellent recreational and leisure time activities and improve physical and mental health for participants. The Aspen Institute in 2018 reported that more kids are being physically active, more are trying different sports, and multisports play is increasing rather than strict specialization. Unfortunately they note that there is an economic inequality with children from lower-socioeconomic circumstances playing less organized sports. About 70% of children and youth participate in an individual or team sport, but unfo...
Source: PediatricEducation.org - December 7, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

High-dose influenza vaccine shows no additional benefit for heart disease patients
NIH-funded study finds higher dose is not more effective at reducing serious flu complications in this high-risk group. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - December 4, 2020 Category: American Health Source Type: news

Accessing government-secured flu vaccines: guidance for GPs, DHSC (updated 3rd December 2020)
How GP practices in England can access the extra stock of flu vaccines this winter that the government has secured.3 December 2020 Updated to reflect current availability of vaccines (in Table 1). If GP practices need further stock, they should now order Adjuvanted Trivalent Influenza Vaccine (aTIV) for those over 65 years old or QIVc (cell-grown quadrivalent influenza vaccine) for those under 65 years old. Both are available to order from Seqirus. 20 November 2020 Updated to include information about which additional vaccines are available (including Flublok ® ) in Appendix A, and the expansion of the programme ...
Source: Current Awareness Service for Health (CASH) - December 4, 2020 Category: Consumer Health News Source Type: news

Inactivated influenza vaccine: information for healthcare practitioners - update, PHE (updated 1st December 2020)
Additional information is included, covering additional detail on the expansion of the flu vaccination programme to 50 to 64 year olds, and information about the recombinant quadrivalent influenza vaccine Flublok and its authorisation for temporary supply under regulation 174. 1 December 2020 Added updated guidance. 11 September 2020 Added guidance for the winter 2020 to 2021 flu programme. 26 November 2019 Updated antibiotic section and reference to gelatin. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 3, 2020 Category: Consumer Health News Source Type: news

What You Need to Know About COVID-19 and Flu
Every winter is a bit of a roulette wheel when it comes to influenza. Flu vaccines work, but aren’t 100% effective in preventing disease, so it’s always a challenge convincing people to get their flu shots. And while the symptoms are generally bearable, infections can become more severe and even deadly among people who are older or who have underlying health conditions. Last flu season, even though experts considered it a relatively mild year, about 400,000 people in the U.S. were hospitalized and 22,000 people died from the flu. This winter, the influenza virus has a rival—the coronavirus fueling the COV...
Source: TIME: Health - December 2, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Seasonal influenza vaccination good value for money for most risk groups in South Africa
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2020 Category: Drugs & Pharmacology Source Type: news

COVID-19: A data challenge and a catalyst for new insights
  One of the key issues that arose during the pandemic, and arguably a factor that has led to more deaths, has been one of healthcare systems, public health and governments having insufficient or no relevant data on which to base critical decisions. The right data are not in the right place to answer the right questions at the right time. Yet, in the midst of this we have also seen remarkable collaboration on the scientific response to the pandemic, from diagnostics to therapeutic and vaccine research and development. We have learned a lot about the virus since its genome was shared by Chinese researchers in Jan...
Source: EyeForPharma - November 24, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news

Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person
             Basel, 24 November 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone with influenza (known as post-exposure prophylaxis). Xofluza is the first single-dose influenza medicine approved for post-exposure prophylaxis.“With today’s approval, Xofluza is now available as the first single-dos...
Source: Roche Media News - November 24, 2020 Category: Pharmaceuticals Source Type: news

Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person
             Basel, 24 November 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) as a treatment to prevent influenza in people 12 years of age and older following contact with someone with influenza (known as post-exposure prophylaxis). Xofluza is the first single-dose influenza medicine approved for post-exposure prophylaxis.“With today’s approval, Xofluza is now available as the first single-dos...
Source: Roche Investor Update - November 24, 2020 Category: Pharmaceuticals Source Type: news

Flu symptoms mimic COVID-19 infection: experts urge flu vaccination
Cases of?influenza?are being reported in parts of the U.S. as the?COVID-19?pandemic continues. While a vaccine is not yet available for COVID-19, there is a vaccine available to prevent influenza.? "This season is more important to get the flu vaccine because the flu also has symptoms that mimic COVID-19 infection," says Dr. Robert Jacobson, a pediatrician and vaccine [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 23, 2020 Category: Databases & Libraries Source Type: news